Are you Dr. Li?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin St
# M227
Houston, TX 77030Phone+1 713-441-3490Fax+1 713-793-1603
Summary
- Dr. Xiaoxian Li, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Georgia and California. He is affiliated with Emory University Hospital.
Education & Training
University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2012 - 2013
Methodist Hospital (Houston)Residency, Pathology-Anatomic and Clinical, 2007 - 2011
Beijing Medical UniversityClass of 1997
Certifications & Licensure
CA State Medical License 2011 - 2027
GA State Medical License 2013 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 2 citationsLow interobserver agreement among subspecialised breast pathologists in evaluating HER2-low breast cancer.Gulisa Turashvili, Yuan Gao, Di Andy Ai, Abdulwahab M Ewaz, Sandra Gjorgova Gjeorgjievski
Journal of Clinical Pathology. 2024-11-19 - Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer.Lisa A Ridnour, William F Heinz, Robert Y S Cheng, Adelaide L Wink, Noemi Kedei
Cancer Research Communications. 2024-10-01 - Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival.Lara Schwieger, Lauren M Postlewait, Yi Liu, Stephanie Jou, Sha Yi
Breast Cancer Research and Treatment. 2024-09-01
Press Mentions
Prognostic Value of Programmed Cell Death Ligand-1 Expression in Breast CancerDecember 4th, 2020- Molecular Pathology Selected AbstractsMarch 22nd, 2024
